Go to content

Risk stratification for prevention of venous thromboembolism in hospitalized medical patients: can thromboprophylaxis in hospitalized medical patients be safely restricted to reduce costs?

Share

Please join us …

When: Tuesday, October 10, 2017, 12–1 p.m.

Where: ICES, G-Wing, Conference Centre (Sunnybrook Health Sciences Centre)

Who: Alison Bond, PharmD; Sunnybrook Health Sciences Centre, Thromboembolism Pharmacy Fellow.

Topic: Risk stratification for prevention of venous thromboembolism in hospitalized medical patients: can thromboprophylaxis in hospitalized medical patients be safely restricted to reduce costs?

Learning objectives

  1. To describe the benefits and harms of thromboprophylaxis
  2. To summarize the evidence to support thromboprophylaxis in GIM patients
  3. To evaluate the potential impact of risk assessment models for thromboprophylaxis in GIM patients.
Alison Bond

Alison Bond

Information

Associated Sites